Fact checked by Nick Blackmer In a new study, semaglutide reduced liver fat, inflammation, and scarring in people with ...

As medications become increasingly popular to support weight loss, not all of them are approved by the U.S. Food and Drug ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...